Summary
- Current Price
- As of today, RGNX price is $10.08, down -4.45% on
- Current Price All-Time High
- RGNX price is currently -88.16% below its historical high of $85.10 set on
- Market Cap
- RGNX current market cap is $520M, up +37.94% over the past 365 days
- PE Ratio
- RGNX PE ratio is unknown
- Revenue
- RGNX current annual revenue is $170.44M, up +104.54% year-over-year
- Next Earnings
- The next earnings release for RGNX is on
Profile
| Metric | Value |
|---|---|
| Full Name | REGENXBIO Inc. |
| Ticker | NASDAQ: RGNX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | regenxbio.com |
| Employees | 353 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $10.08 | |
| Price, 1D Change | -4.45% | |
| $520M | ||
| - | ||
| - | ||
| 2.50 | ||
| $170M | ||
| Revenue, 1Y Change | +104.54% | |
| -$3.76 | ||
| EPS, 1Y Change | +18.05% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$3.76 | ||
| EPS Estimate | N/A | -$2.00 |
| EPS Est. Change | N/A | +46.83% |
| $170.44M | ||
| Revenue Estimate | N/A | $255.53M |
| Revenue Est. Change | N/A | +49.93% |
| Current Price | $10.08 | |
| Price Target | - | $27.00 |
| Price Tgt. Change | - | +167.86% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$4.76 | -$4.59 | +3.59% | |
| -$3.30 | -$3.76 | -14.02% | |
| -$2.00 | N/A | +46.83% | |
| -$2.20 | N/A | +41.58% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $87.11M | $83.33M | -4.34% | |
| $185.98M | $170.44M | -8.36% | |
| $255.53M | N/A | +49.93% | |
| $305.95M | N/A | +79.50% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $10.08 | |
| $10.57 | ||
| SMA 200 vs Price | +4.87% | |
| $8.95 | ||
| SMA 50 vs Price | -11.19% | |
| 2.50 | ||
| $0.66 | ||
| 59.81 | ||
| 72.52% | ||
| 78.98% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $170.44M | ||
| -$3.76 | ||
| $150.14M | ||
| 88.09% | ||
| -$161.20M | ||
| -94.58% | ||
| -$193.88M | ||
| -113.75% | ||
| -$145.58M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 2.54 | ||
| 2.38 | ||
| 2.38 | ||
| - | ||
| 3 | ||
| -2.95 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 3.05 | ||
| 5.06 | ||
| -3.78 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $102.73M | ||
| $230.07M | ||
| $453.03M | ||
| $281.28M | ||
| $350.30M | ||
| $118.10M | ||
| $260.52M | ||
| $47.90M | ||
| $21.36M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $364.32M | ||
| $311.34M | ||
| $20.30M | ||
| $0.00 | ||
| $15.62M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$123.96M | ||
| -$15.87M | ||
| $116.77M | ||
| $2.41M | ||
| -$126.38M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| Morgan Stanley | → | |
| Morgan Stanley | → | |
| HC Wainwright & Co. | → | |
| Goldman Sachs | → | |
| Chardan Capital | → | |
| Chardan Capital | → | |
| Stifel | → | |
| Leerink Partners | → | |
| Chardan Capital | → |
Analyst sentiment
Institutional ownership
Screeners with RGNX
FAQ
What is the ticker symbol for REGENXBIO Inc.?
The ticker symbol for REGENXBIO Inc. is NASDAQ:RGNX
Does REGENXBIO Inc. pay dividends?
No, REGENXBIO Inc. does not pay dividends
What sector is REGENXBIO Inc. in?
REGENXBIO Inc. is in the Healthcare sector
What industry is REGENXBIO Inc. in?
REGENXBIO Inc. is in the Biotechnology industry
What country is REGENXBIO Inc. based in?
REGENXBIO Inc. is headquartered in United States
When did REGENXBIO Inc. go public?
REGENXBIO Inc. initial public offering (IPO) was on September 17, 2015
Is REGENXBIO Inc. in the S&P 500?
No, REGENXBIO Inc. is not included in the S&P 500 index
Is REGENXBIO Inc. in the NASDAQ 100?
No, REGENXBIO Inc. is not included in the NASDAQ 100 index
Is REGENXBIO Inc. in the Dow Jones?
No, REGENXBIO Inc. is not included in the Dow Jones index
When was REGENXBIO Inc. last earnings report?
REGENXBIO Inc.'s most recent earnings report was on March 5, 2026
When does REGENXBIO Inc. report earnings?
The next expected earnings date for REGENXBIO Inc. is May 14, 2026
Data Sources & References
- RGNX Official Website www.regenxbio.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1590877/000119312526094013/0001193125-26-094013-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1590877/000119312526094013/0001193125-26-094013-index.htm
- RGNX Profile on Yahoo Finance finance.yahoo.com/quote/RGNX
- RGNX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rgnx